Sellbyville, DE -- (SBWIRE) -- 11/16/2018 -- Global Breast Implants Market set to exceed USD 4 billion by 2024; according to a new research study published by Global Market Insights, Inc. Rising number of breast augmentation procedures coupled with increasing breast cancer incidence will drive breast implants market size over the forecast timeframe. Augmentation procedures enable women to increase their breast size and improves bust and hip contour balance. Reconstruction procedures help to restore one or both breasts to near normal size, shape and appearance.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2020

High cost of implantation procedure will impede industry expansion. Risk of complications in the case of both saline and silicone implants further limits procedure adoption. Complications associated with the procedure include infection, scarring, capsular formation and contraction, sensation changes to breast and nipple and chances of implant rupture. Additional surgeries may be required for treating the same.

Silicone breast implants market accounted for the largest revenue share due to its resemblance to natural breast tissue. Other benefits such as reduced probability of rippling and wrinkling further boosts adoption. However, difficulty of detecting device rupture restrains segment expansion. The rupture can only be detected after conducting an MRI.

Anatomical breast implants market is poised to grow at a lucrative pace owing to its sloped contour with more implant material located at the bottom that provides a more natural appearance. These inserts provide greater projection with same volume as compared to round shaped ones. However, risk of rotation and rippling coupled with higher costs restrains segment growth of breast implants market.

Application of the inserts in breast reconstruction will grow at a rapid rate over the forecast time frame due to increasing incidence of breast cancer. Growing awareness regarding reconstruction surgery has resulted in increasing procedure adoption. Advantages of the reconstruction surgery such as short duration and less complex nature along with little scarring should further escalate demand. However, risks of complications such as infections, bleeding and delayed healing limits adoption rate to some extent.

U.S. breast implants market held significant industry share. Increasing number of women opting for augmentation procedures will drive growth. Increasing per capita expenditure on cosmetic procedures will serve to be a high impact rendering factor.

South Korea breast implants market is slated to witness robust growth over the forecast years. Increasing number of clinics and hospitals catering to plastic surgery coupled with increasing number of plastic surgeons is driving industry growth. Increasing desire to look attractive for excelling in professional life further fuels demand. Furthermore, growing influx of overseas patients especially from neighboring countries augments industry expansion.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2020

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
Allergan (Actavis), Sientra Inc., Mentor Worldwide LLC (Johnson & Johnson), Laboratoires Arion, GC Aesthetics, POLYTECH Health and Aesthetics GmbH, Hansbiomed Co. Ltd., Establishment Labs S.A.